PresentationDRUG DISCOVERY Defining Drug Targets in Yeast Haploinsufficiency Screens: Application to Human Translational Pharmacology Michel Roberge*Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.↵*Presenter and corresponding author. E-mail, michelr{at}interchange.ubc.ca See allHide authors and affiliations Science Signaling 26 Aug 2008:Vol. 1, Issue 34, pp. pt5DOI: 10.1126/scisignal.134pt5 Michel Roberge Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.Find this author on Google Scholar Find this author on PubMed Search for this author on this site Article Figures & Data Info & Metrics eLetters PDF Article Information vol. 1 no. 34 pt5 DOI: https://doi.org/10.1126/scisignal.134pt5 PubMed: 18728306 Published By: Science Signaling Print ISSN: 1945-0877 Online ISSN: 1937-9145 History: . Copyright & Usage: American Association for the Advancement of Science Author Information Michel Roberge*Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.↵*Presenter and corresponding author. E-mail, michelr{at}interchange.ubc.ca Altmetric Article usage Article lifetimeLast 6 monthsThis monthArticle usage: August 2008 to April 2021 AbstractFullPdf Aug 20082058359 Sep 20082358879 Oct 20081002920 Nov 2008684119 Dec 2008481812 Jan 2009692016 Feb 2009361712 Mar 200964116 Apr 20094895 May 20094584 Jun 20093784 Jul 20092131 Aug 20092452 Sep 20093153 Oct 20093373 Nov 20091743 Dec 20091684 Jan 201014913 Feb 20101942 Mar 201020108 Apr 20101652 May 20101165 Jun 20101132 Jul 20101766 Aug 20102416 Sep 20101623 Oct 20102145 Nov 20101534 Dec 20101265 Jan 20112436 Feb 20111836 Mar 20112431 Apr 2011910 May 20112443 Jun 20111302 Jul 20111111 Aug 20111613 Sep 2011821 Oct 20111655 Nov 20112465 Dec 20112122 Jan 20121732 Feb 20121622 Mar 20122241 Apr 20122662 May 20122533 Jun 20121900 Jul 20122203 Aug 20122042 Sep 20121802 Oct 20121711 Nov 20121611 Dec 20121400 Jan 20132012 Feb 20131222 Mar 20131201 Apr 20131812 May 20133151 Jun 20132610 Jul 20132668 Aug 20132231 Sep 20132314 Oct 20132511 Nov 20131623 Dec 20132304 Jan 20141400 Feb 20141813 Mar 20142946 Apr 20141622 May 20142011 Jun 20141826 Jul 20141113 Aug 2014703 Sep 20142550 Oct 20141113 Nov 20142211 Dec 20141201 Jan 20152524 Feb 2015911 Mar 2015700 Apr 20151411 May 2015821 Jun 20151400 Jul 20151862 Aug 20151200 Sep 20159754 Oct 20151411 Nov 20151911 Dec 2015803 Jan 20161701 Feb 20161112 Mar 20161412 Apr 2016900 May 20165405 Jun 20163222 Jul 20165833 Aug 20162312 Sep 20164803 Oct 20161710 Nov 20161932 Dec 20161210 Jan 20172811 Feb 20172421 Mar 20172121 Apr 20171420 May 20172111 Jun 20171921 Jul 20171911 Aug 20173422 Sep 20172433 Oct 20171524 Nov 20171910 Dec 20171320 Jan 20182540 Feb 20184246 Mar 20182830 Apr 20183743 May 20184613 Jun 20184010 Jul 20182520 Aug 20182840 Sep 20182054 Oct 20184150 Nov 20183750 Dec 20182930 Jan 20194262 Feb 201947142 Mar 20192110 Apr 20191141 May 20191340 Jun 20192462 Jul 20192531 Aug 20191172 Sep 20191210 Oct 20191440 Nov 20191210 Dec 20191610 Jan 20201560 Feb 20201310 Mar 2020631 Apr 2020921 May 20201911 Jun 20202230 Jul 20201010 Aug 2020320 Sep 20201341 Oct 20201292 Nov 20201531 Dec 20201552 Jan 20211041 Feb 20213610 Mar 20211120 Apr 2021830 View Full Text
Defining Drug Targets in Yeast Haploinsufficiency Screens: Application to Human Translational Pharmacology By Michel Roberge Science Signaling26 Aug 2008 : pt5 Identifying targets of drugs in yeast using genome-wide drug-induced haploinsufficiency is a viable approach to predicting drug targets in humans.
Defining Drug Targets in Yeast Haploinsufficiency Screens: Application to Human Translational Pharmacology By Michel Roberge Science Signaling26 Aug 2008 : pt5 Identifying targets of drugs in yeast using genome-wide drug-induced haploinsufficiency is a viable approach to predicting drug targets in humans.